1. Home
  2. >>Scrip
  3. >>Business
  4. >>Deals
  5. >>Deal Watch

Deal Watch

Asia Deal Watch: Regenxbio Licenses Two MPS Gene Therapies To Nippon Shinyaku

 
• By Joseph Haas, Lisa Takagi, and Dexter Jie Yan

Plus deals involving Simcere/AbbVie, Daiichi Sankyo/Glycotope, Telix/ImaginAb, Harbour/Kelun/Windward, Insilico/Menarini, Samsung Bioepis/Teva, HealZen/J&J, Zai Lab/Vertex, Zai Lab/MediLink and Primrose/Serum Institute of India.

Deal Watch: Bausch Companies Set Hectic Pace At J.P. Morgan With Five Deals

 
• By Joseph Haas

Plus deals involving Lantheus/Life Molecular Imaging, Teva/Klinge/Formycon, X4/Norgine, Biohaven/Merus, Lilly/Mediar and more.

Deal Watch: Lilly Looks To Alchemab’s ‘Resilient’ Antibodies To Take On ALS

 
• By Joseph Haas and Jung Won Shin

Plus deals involving Synaffix/Mitsubishi Tanabe/Boehringer Ingelheim, Newron/Myung In, Vividion/Tavros, Novo Nordisk/Variant, Vertex/Orna, Sanofi/Alloy and more.

Deal Watch: Regeneron Quietly Acquires UK Ophthalmology Firm Oxular

 
• By Joseph Haas and Dexter Jie Yan

Plus deals involving Pfizer/Atavistik, Immedica/Marinus, J&J/Kaken, Ikena/Inmagene, Corxel/Vincentage, Rapt/Jemincare, Sanofi/Corxel, Bristol Myers Squibb/BioArctic, NGM/kdT Ventures and more.

Asia Deal Watch: Kaken Obtains Aadi Subsidiary And Cancer Drug Fyarro

 
• By Joseph Haas, Lisa Takagi, Ian Haydock, and Vibha Ravi

Plus deals involving Hangzhou DAC/Aadi, Astellas/Sangamo, Kyorin/Bayer, Eisai/Newron, Lupin/Boehringer Ingelheim, Asahi Kasei/Chiome and more.

Deal Watch: Merck Decides Better Late Than Never In GLP-1 Deal With Hansoh

 
• By Joseph Haas

Plus deals involving Novartis/BioAge, Novo Nordisk/Photys, Tvardi/Cara, Gilead/Terray, Candid/Ab Studio/EpimAb/Nona, AbbVie/Nimble and more.

Deal Watch: GSK Extends Its Shingrix Alliance In China With Zhifei

 
• By Joseph Haas

Plus deals involving Mitsubishi Tanabe/Dewpoint, Lilly/Rondo, Ono/Congruence, Bristol Myers Squibb/AI Proteins and more.

Deal Watch: Sarepta Targets RNAi In Broad Collaboration With Arrowhead

 
• By Joseph Haas

Plus deals involving Novartis with Vyriad, Ratio and Schrödinger; Pharmanovia/Lindis, Pulmatrix/Cullgen, Entero/Journey, Roche/Flare and AlloVir/Kalaris.

Asia Deal Watch: Otsuka Lands Second Alliance With Ionis, Focused On ALS Subpopulation

 
• By Joseph Haas, Jung Won Shin, and Lisa Takagi

Plus deals involving Zai Lab/Pfizer, Laekna/Lilly, Takeda/Alloy, Lunit/AstraZeneca, VelaVigo/Avenzo, Biosion/Aclaris, HCW/WY Biotech, Celltrion/iQone and Kaken/Numab.

Deal Watch: Renexxion To Go Public While Avid Biosciences Goes Private

 
• By Joseph Haas

Plus deals involving Synaffix/BigHat, AbbVie/EvolveImmune, Servier/Aitia, Dr. Falk/Kynos, Bayer/Dewpoint and more.

Asia Deal Watch: Cureverse Licenses Option For Neurology Candidate To Angelini

 
• By Joseph Haas, Lisa Takagi, Dexter Jie Yan, and Jung Won Shin

Plus deal news involving LianBio/NImmune, REGiMMUNE/Kiji, Chengdu Baiyu/Novartis, Orasis/Optus, Takeda/Wave Life Sciences, Ono/LigaChem, Alchem/Sonnet, Astellas/AviadoBio, Innovent/Ask Pharm and Dr Reddy’s/Gilead.

Deal Watch: MacroGenics Offloads Margenza To TerSera As Focus Shifts To Pipeline

 
• By Joseph Haas

Lilly unit explores external innovation with insitro and Qinotto, plus deals involving Novartis/3BP, Eterna/Factor, Molecure/Ocean, Bayer/MOMA, Virios/Wex and more.

Deal Watch: Shionogi Will Market Nxera’s Insomnia Drug In Japan

 
• By Joseph Haas, Lisa Takagi, Vibha Ravi, and Dexter Jie Yan

Plus deals involving Jiangsu Alphamab/CSPC, Zydus/CDRI, Junshi/JSIAMA, Repair/Genevant, Sanofi/I-Mab, Novartis/Mitem and BioAtla/Context.

Deal Watch: A Closer Look At Boehringer Ingelheim’s Partnering Strategy

 
• By Joseph Haas, Vibha Ravi, and Lisa Takagi

Plus deals involving AbbVie/Ripple, Novo Nordisk/Korro Bio, Novo Nordisk/NanoVation, Bharat, Alopexx, Gilead/Genesis, Lilly/Genetic Leap, Contraline/Population Council, Proveca/Cessatech, Vivtex/Equillium and more.

Asia Deal Watch: EpimAb Licenses Bispecific Antibody To Newly Formed Vignette

 
• By Joseph Haas, Dexter Jie Yan, Xu Hu, and Lisa Takagi

Also including deals between EpimAb/Vignette, Allist/Jacobio, Rigel/Kissei, Simcere/TargetRx, Altamira/Nuance, PharmaEssentia/Forus and Chugai/LTL.

Deal Watch: Lilly Turns To Oblique For Antibody Discovery

 
• By Joseph Haas

Plus deals involving Lilly/Oblique, Rafael Holdings/Cyclo, ADCendo/Multitude, Ocuvex/Visiox and more.

Deal Watch: Revance To Go Private In Crown Laboratories Buyout

 
• By Joseph Haas and Vibha Ravi

Plus deals involving AstraZeneca/Conduit, Recursion/Exscientia, G1/Pharmacosmos, Sanofi/Vir, Passage Bio/GEMMA and Lupin/Evofem. Also including deals in brief.

Asia Deal Watch: Ocumension Obtains Chinese Rights To Eight Alcon Products

 
• By Joseph Haas, Dexter Jie Yan, Vibha Ravi, and Anju Ghangurde

Also deals involving WuXi/Medigene, Eisai/Seed, Genor/Two River/Third Rock Ventures, ImmuneOnco/Instil, Biocytogen/Ideaya, Takeda/Dr Reddy’s/Zydus/Mankind and deals in brief.

Deal Watch: BI Acquires Nerio For Novel Immune Checkpoint Inhibitor

 
• By Joseph Haas and Mary Jo Laffler

Featuring deals involving Novartis/Dren, Palvella/Pieris, Eyenovia/Senju, Addex/Johnson & Johnson, Agilent/BioVectra, Meitheal/Nabriva, plus tech transfer agreements and deals in brief.

Asia Deal Watch: Orum, Vertex Team Up On Gene Editing Conditioning Agents

 
• By Joseph Haas, Dexter Jie Yan, Lisa Takagi, and Jung Won Shin

Plus deals involving Eisai/Sato, Keymed/Belenos, Taiho/Arcus, IASO/Innovent, Biocytogen/SOTIO, Ensol/Spine, TMS/Hokkaido University and Yuhan/Ubix.